3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Conditions
Rectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
6
Esophageal Neoplasms
6
Oropharyngeal Neoplasms
5
Uterine Cervical Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Hypopharyngeal Neoplasms
3
Radiation Injuries
2
Nasopharyngeal Carcinoma
2
Lung Neoplasms
2
Laryngeal Neoplasms
2
Glioblastoma
2
Esophageal Squamous Cell Carcinoma
2
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Malignant Neoplasms
1
Postoperative Complications
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Ototoxicity
1
Neoplasms
1
Myelosuppression
1
Mouth Neoplasms
1
Margins of Excision
1
Malignant Tumor of Lacrimal Drainage Structure
1
Low Anterior Resection Syndrome
1
Locally Advanced Hypopharyngeal Carcinoma
1
Interventions
pembrolizumab
38
Blood Specimen Collection
38
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
17
Exercise
17
Carboplatin
17
Nivolumab
15
atezolizumab
14
Paclitaxel
14
Cisplatin
14
Drug Therapy
13
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
11
Trastuzumab
10
Pemetrexed
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Chemoradiotherapy
×
Clear all
NCT06551857
2025-04-16
CaSPiN
Turku University Hospital
Recruiting
250 enrolled